Skip to main content

Table 1 Baseline data of two groups of patients

From: A retrospective analysis of the clinical efficacy of pancreatic duct stent implantation in the management of acute biliary pancreatitis requiring ERCP

Variable

Pancreatic duct stent group (n = 141)

Non-pancreatic duct stent group (n = 88)

P

Age (years, \(\overline{\mathrm{x} }\) ± s)

61.53 ± 15.72

63.25 ± 13.76

0.360

Gender (n, %)

0.891

 Male

80 (56.74%)

51 (57.95%)

 Female

61 (43.26%)

37 (42.05%)

APACHE II [score, M(IQR)]

8.00 (4.00–12.00)

7.00 (4.00–10.00)

0.400

Moderate and severe ABP (n, %)

95 (67.38%)

48 (54.55%)

0.068

OF (n, %)

55 (39.01%)

26 (29.55%)

0.158

Cholangitis or biliary obstruction (n, %)

86 (60.99%)

44 (50.00%)

0.067

Bilirubin levels

34.91 ± 4.86

35.71 ± 5.23

0.352